01Manufacturing conversation that starts with the product
Begin with dosage form, pack, approximate quantity and target market. The SRS team can then review the appropriate manufacturing and commercial route rather than forcing every enquiry into one template.
02Multiple dosage-form references
The current public portfolio includes syrups and liquids, capsules, tablets, softgels, churna and oils. Product availability and manufacturing feasibility remain subject to documentation and requirement review.
03Built for B2B follow-up
Every public product can connect to bulk-price or third-party enquiry paths, helping business visitors move from discovery to a trackable commercial conversation.